This report offers companies, investors, policymakers, and stakeholders crucial insight into Greece; a country with an admirable and long-standing history in healthcare and pharmaceuticals, but one that is still struggling to find its way out of a national debt crisis. The interviewees from government, associations, MNCs and local players featured in the report discuss the various issues and barriers to growth created by economic austerity policies, but also how innovative and quick-thinking players have found opportunity in crisis and are adapting to the new reality.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on Greece’s macroeconomic situation, as well as its healthcare and pharma sectors.